Effect of lipid modification on progression of coronary calcification
- PMID: 16251246
- DOI: 10.1681/ASN.2005060664
Effect of lipid modification on progression of coronary calcification
Abstract
Coronary artery calcification (CAC) reflects the anatomic presence of coronary atherosclerosis and the relative burden of coronary artery disease (CAD). Higher levels of CAC are seen in the presence of CAD risk factors, older age, and chronic kidney disease. The lipid profile (primarily low HDL cholesterol, elevated triglycerides, elevated LDL cholesterol, and elevated total cholesterol) are important factors in the calcification process. The annual progression of CAC can be reduced from 25 to 30% to 0 to 6% with LDL cholesterol reduction caused by statins and possibly sevelamer. At treated LDL cholesterol levels somewhere below 100 mg/dl, several sources of data suggest the anatomic burden of CAD, including CAC, regresses. Additional supportive studies indicate that carotid intimal medial thickness and the volume of coronary atheroma also can be reduced by LDL cholesterol reduction in concert with elevation of HDL cholesterol. This article reviews the data in support of altering the natural history of CAC with lipid modification.
Similar articles
-
Lipid management with statins. The lower the better?Z Kardiol. 2004 Jan;93(1):4-9. doi: 10.1007/s00392-004-1023-y. Z Kardiol. 2004. PMID: 14740235 Review.
-
Risk factors for coronary artery disease in patients with elevated high-density lipoprotein cholesterol.Am J Cardiol. 2007 Jan 1;99(1):1-4. doi: 10.1016/j.amjcard.2006.07.053. Epub 2006 Nov 2. Am J Cardiol. 2007. PMID: 17196452
-
Relation of coronary calcium progression and control of lipids according to National Cholesterol Education Program guidelines.Am J Cardiol. 2004 Aug 15;94(4):431-6. doi: 10.1016/j.amjcard.2004.05.003. Am J Cardiol. 2004. PMID: 15325924
-
Hypercholesterolemia. The evidence supports use of statins.Geriatrics. 2003 Aug;58(8):18-20, 26-8, 31-2. Geriatrics. 2003. PMID: 12938249
-
Effects of modifying triglycerides and triglyceride-rich lipoproteins on cardiovascular outcomes.J Cardiovasc Pharmacol. 2008 Apr;51(4):331-51. doi: 10.1097/FJC.0b013e318165e2e7. J Cardiovasc Pharmacol. 2008. PMID: 18427276 Review.
Cited by
-
Expression of NPP1 is regulated during atheromatous plaque calcification.J Cell Mol Med. 2011 Feb;15(2):220-31. doi: 10.1111/j.1582-4934.2009.00988.x. J Cell Mol Med. 2011. PMID: 20015201 Free PMC article.
-
Familial defective apolipoprotein B-100 and increased low-density lipoprotein cholesterol and coronary artery calcification in the old order amish.Arch Intern Med. 2010 Nov 8;170(20):1850-5. doi: 10.1001/archinternmed.2010.384. Arch Intern Med. 2010. PMID: 21059979 Free PMC article.
-
Plasma prekallikrein levels are positively associated with circulating lipid levels and the metabolic syndrome in children.Appl Physiol Nutr Metab. 2010 Aug;35(4):518-25. doi: 10.1139/H10-039. Appl Physiol Nutr Metab. 2010. PMID: 20725119 Free PMC article.
-
Comparison of the effects of lanthanum carbonate and calcium carbonate on the progression of cardiac valvular calcification after initiation of hemodialysis.BMC Cardiovasc Disord. 2020 Jan 30;20(1):39. doi: 10.1186/s12872-020-01343-1. BMC Cardiovasc Disord. 2020. PMID: 32000687 Free PMC article.
-
Predictive nomogram model for severe coronary artery calcification in end-stage kidney disease patients.Ren Fail. 2024 Dec;46(2):2365393. doi: 10.1080/0886022X.2024.2365393. Epub 2024 Jun 14. Ren Fail. 2024. PMID: 38874139 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous